<DOC>
	<DOCNO>NCT01615783</DOCNO>
	<brief_summary>Reports suggest Medicaid population include high percentage smoker general population . A high prevalence smoker population likely lead high burden chronic obstructive pulmonary disease ( COPD ) . Few study evaluate economic burden COPD Medicaid population . The objective observational , retrospective cohort study estimate economic burden COPD subject COPD diagnosis enrol Medicaid receive maintenance treatment cover Medicaid . Specifically , null hypothesis primary outcome measure difference observe all-cause cost subject without COPD . The test hypothesis difference all-cause cost subject without COPD . Secondary outcomes evaluate include all-cause resource use COPD-related cost COPD cohort . The study use medical pharmacy administrative claim database call MarketScan Medicaid Database contain medical , surgical , prescription drug experience nearly 7 million Medicaid recipient . This analysis use data 8 state .</brief_summary>
	<brief_title>Clinical Economic Burden Patients With Chronic Obstructive Pulmonary Disease Medicaid Population</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>least 40 year age index date continuously eligible receive healthcare service Medicaid preindex followup period enrol feeforservice plan without diagnosis code exclusionary comorbid condition cystic fibrosis , bronchiectasis , respiratory cancer , pulmonary fibrosis , pneumoconiosis , sarcoidosis , pulmonary tuberculosis ( include fibrosis due tuberculosis ) age less 40 index date</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>Costs</keyword>
	<keyword>Resource utilization</keyword>
	<keyword>Medicaid</keyword>
</DOC>